Nonsurgical, image-guided, minimally invasive therapy for thyroid nodules

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 10, 2013, Pages 3949-3957

  Gharib, Hossein ^a   Hegedüs, Laszlo ^b   Pacella, Claudio Maurizio ^d   Baek, Jung Hwan ^c   Papini, Enrico ^d  

^a Mayo Clinic College of Medicine   (United States)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c University of Ulsan College of Medicine   (South Korea)

^d REGINA APOSTOLORUM HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; RADIOACTIVE IODINE;

ABLATION THERAPY; BLEEDING; BLISTER; BURN; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; HEALTH CARE COST; HEMATOMA; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; LARYNGEAL NERVE INJURY; MICROWAVE THERAPY; MINIMALLY INVASIVE PROCEDURE; NECK PAIN; NODULAR GOITER; NONHUMAN; PARATHYROID TUMOR; PERCUTANEOUS ETHANOL INJECTION THERAPY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SAFETY; THYROID CANCER; THYROID CYST; THYROID FUNCTION; THYROID MASS; THYROID NODULE; TREATMENT INDICATION; ULTRASOUND GUIDED LASER; UTERINE CERVIX CANCER; VAGUS NERVE INJURY; VOCAL CORD PARALYSIS; CATHETER ABLATION; METHODOLOGY; MICROWAVE RADIATION; RECURRENT DISEASE; PROCEDURES;

CATHETER ABLATION; ETHANOL; HUMANS; MICROWAVES; RECURRENCE; THYROID NODULE;

EID: 84885216427     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1806     Document Type: Review

References (69)

1. Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am. 2007; 36: 707-735.
2. Gharib H, Papini E, Paschke R., et al American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. J Endocrinol Invest. 2010; 33(5 suppl):51-56.
3. Cooper DS, Doherty GM, Haugen B.R., et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19: 1167-1214.
4. Bergenfelz A, Jansson S, Kristoffersson A., et al Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3, 660 patients. Langenbecks Arch Surg.2008; 393: 667-673.
5. Bennedbaek FN, Karstrup S, Hegedüs L. Percutaneous ethanol injection therapyin the treatment of thyroid and parathyroid diseases. Eur J Endocrinol. 1997; 136: 240-250.
6. Hegedüs L. Therapy: a new nonsurgical therapy option for benign thyroid nodules? Nat Rev Endocrinol. 2009; 5: 476-478.
7. Paschke R, Hegedüs L, Alexander E., Valcavi R, Papini E, Gharib H. Thyroid nodule guidelines: agreement, disagreement and need for future research. Nat Rev Endocrinol. 2001; 7: 354-361.
8. Burman KD. Treatment of recurrent or persistent cervical node metastases in differentiated thyroid cancer: deceptively simple options. J Clin Endocrinol Metab. 2012; 97: 2623-2625.
9. Hay ID, Charboneau JW The coming of age of ultrasound-guided percutaneous ethanol ablation of selected neck nodal metastases in well-differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2011; 96: 2717-2720.
10. Heilo A, Sigstad E, Fagerlid K.H., et al. Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma. J Clin Endocrinol Metab. 2011; 96: 2750-2755.
11. Bennedbaek FN, Nielsen LK, Hegedüs L. Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial. J Clin Endocrinol Metab. 1998; 83: 830-835.
12. Bennedbaek FN, Hegedüs L. Percutaneousethanol injection therapy in benign solitary solid cold thyroid nodules: a randomized trial comparing one injection with three injections. Thyroid. 1999; 9: 225-233.
13. Watt T, Hegedüs L, Groenvold M., et al Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. Eur J Endocrinol. 2010; 162: 161-167.
14. Hegedüs L., Bonnema SJ, Bennedbaek FN Management of simple nodular goiter: current status and future perspectives. Endocr Rev. 2003; 24: 102-132.
15. Hegedüs L., Hansen JM, Karstrup S, Torp-Pedersen S, Juul N. Tetracycline for sclerosis of thyroid cysts. A randomized study. Arch Intern Med. 1988; 148: 1116-1118.
16. Bennedbaek FN, Hegedüs L. Treatment of recurrent thyroid cysts with ethanol: a randomized double-blind controlled trial. J Clin Endocrinol. 2003; 88: 5773-5777.
17. Kim YJ, Baek JH, Ha E.J., et al Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors. Eur Radiol. 2012; 22: 1573-1578.
18. Bonnema SJ, Hegedüs L. Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome. Endocr Rev. 2012; 33: 920-980.
19. Bahn RS, Burch HB, Cooper D.S., et al Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract. 2011; 17: 456-520.
20. Nygaard B, Hegedüs L, Nielsen K.G., Ulriksen P., Hansen JM Longterm effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules. Clin Endocrinol (Oxf). 1999; 50: 197-202.
21. Monzani F, Caraccio N, Goletti O., et al Treatment of hyper functioning thyroid nodules with percutaneous ethanol injection: Eight years' experience. Exp Clin Endocrinol Diabetes. 1998; 106(SUPPL. 4): S54-S58.
22. Yano Y, Sugino K, Akaishi J., et al Treatment of autonomously functioning thyroid nodules at a single institution: radioiodine therapy, surgery, and ethanol injection therapy. Ann Nucl Med. 2011; 25: 749-754.
23. Deandrea M, Limone P, Basso E., et al US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med Biol. 2008; 34: 784-791.
24. Spiezia S, Garberoglio R, Milone F., et al Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid. 2009; 19: 219-225.
25. Baek JH, Kim YS, Lee D, Huh J.Y., Lee JH Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. AJR Am J Roentgenol. 2010; 194: 1137-1142.
26. Baek JH, Lee JH, Valcavi R, Pacella C.M., Rhim H., Na DG. Thermal ablation for benign thyroid nodules: radiofrequency and laser. Korean J Radiol. 2011; 12: 525-540.
27. Faggiano A, Ramundo V, Assanti A.P., et al Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study. J Clin Endocrinol Metab. 2012; 97: 4439-4445.
28. Lim HK, Lee JH, Ha EJ, Sung J.Y., Kim JK, Baek JH. Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients. Eur Radiol. 2013; 23: 1044-1049.
29. Baek JH, Jeong HJ, Kim Y.S., Kwak MS, Lee D. Radiofrequency ablation for an autonomously functioning thyroid nodule. Thyroid. 2008; 18: 675-676.
30. Baek JH, Moon WJ, Kim Y.S., Lee JH, Lee D. Radiofrequency ablation for the treatment of autonomously functioning thyroid nodules. World J Surg. 2009; 33: 1971-1977.
31. Sung JY, Kim YS, Choi H, Lee J.H., Baek JH Optimum first-line treatment technique for benign cystic thyroid nodules: ethanol ablation or radiofrequency ablation? AJR Am J Roentgenol. 2011; 196: W210-W214.
32. Baek JH, Lee JH, Sung J.Y., et al Complications encountered in the treatmentofbenign thyroid nodules with US-guided radiofrequency ablation: a multicenter study. Radiology. 2012; 262: 335-342.
33. Na DG, Lee JH, Jung S.L., et al Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol. 2012; 13: 117-125.
34. Stafford RJ, Fuentes D, Elliott A.A., Weinberg JS, Ahrar K. Laser-induced thermal therapy for tumor ablation. Crit Rev Biomed Eng. 2010; 38: 79-100.
35. Pacella CM, Bizzarri G, Spiezia S., et al Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology. 2004; 232: 272-280.
36. Pacella CM, Bizzarri G, Guglielmi R., et al Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study. Radiology. 2000; 217: 673-677.
37. Døssing H, Bennedbaek F.N., Hegedüs L. Ultrasound-guided interstitial laser photocoagulation of an autonomous thyroid nodule: the introduction of a novel alternative. Thyroid. 2003; 13: 885-888.
38. Rotondi M, Amabile G, Leporati P., Di Filippo B, Chiovato L. Repeated laser thermal ablation of a large functioning thyroid nodule restores euthyroidism and ameliorates constrictive symptoms. J Clin Endocrinol Metab. 2009; 94: 382-383.
39. Døssing H, Bennedbaek FN, Karstrup S, Hegedüs L. Benign solitary solid cold thyroid nodules: US-guided interstitial laser photocoagulation-initial experience. Radiology. 2002; 225: 53-57.
40. Spiezia S, Vitale G, Di Somma C, et al Ultrasound-guided laser thermal ablation in the treatment of autonomous hyperfunctioning thyroid nodules and compressive nontoxic nodular goiter. Thyroid. 2003; 13: 941-947.
41. Gambelunghe G, Fede R, Bini V., et al. Ultrasound-guided interstitial laser ablation for thyroid nodules is effective only at high total amounts of energy: results from athree-year pilot study. Surg Innov. 2013; 20: 345-350.
42. Cakir B, Topaloglu O, Gul K., et al Effects of percutaneous laser ablation treatment in benign solitary thyroid nodules on nodule volume, thyroglobulin and anti-thyroglobulin levels, and cytopa-thology of nodule in 1 yr follow-up. J Endocrinol Invest. 2006; 29: 876-884.
43. Valcavi R, Bertani A, Pesenti M., et al Laser and radiofrequency ablation procedures. In: Baskin HJ, Duick DS, Levine RA, eds. Thyroid ultrasound and ultrasound guided FNA biopsy. 2nd ed. New York, NY: Springer; 2008: 191-218.
44. Valcavi R, Riganti F, Bertani A., Formisano D, Pacella CM Percutaneous laser ablation of cold benign thyroid nodules: a 3-year follow-up study in 122 patients. Thyroid. 2010; 20: 1253-1261.
45. Amabile G, Rotondi M, Pirali B., et al Interstitial laser photocoagulation for benign thyroid nodules: time to treat large nodules. Lasers Surg Med. 2011; 43: 797-803.
46. Gambelunghe G, Fatone C, Ranchelli A., et al A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatmentofbenign thyroid nodules. J Endocrinol Invest. 2006; 29: RC23-RC26.
47. Døssing H, Bennedbaek F.N., Hegedüs L. Effect of ultrasound-guided interstitial laser photocoagulation on benign solitary solid cold thyroid nodules-a randomised study. EurJ Endocrinol. 2005; 152: 341-345.
48. Papini E, Guglielmi R, Bizzarri G., et al Treatment of benign cold thyroid nodules: a randomized clinical trial of percutaneous laser ablation versus levothyroxine therapy or follow-up. Thyroid. 2007; 17: 229-235.
49. Døssing H, Bennedbaek F.N., Hegedüs L. Long-term outcome following interstitial laser photocoagulation of benign cold thyroid nodules. Eur J Endocrinol. 2011; 165: 123-128.
50. Rago T, Papini E, Vitti P., et al A multicenter randomized prospective trial of laser ablation versus follow-up for the treatment of cold thyroid nodules-twelve-month results. In: Proceedings from the 36th Annual Meeting of the European Thyroid Association; September 8-12, 2012; Pisa, Italy. Abstract A-485-0124-00180.
51. Cakir B, Gul K, Ugras S., et al Percutaneous laser ablation of an autonomous thyroid nodule: effects on nodule size and histopathology of the nodule 2 years after the procedure. Thyroid. 2008; 18: 803-805.
52. Barbaro D, Orsini P, Lapi P., et al Percutaneous laser ablation in the treatment of toxic and pretoxic nodular goiter. Endocr Pract. 2007; 13: 30-36.
53. Døssing H, Bennedbaek F.N., Bonnema SJ, Grupe P, Hegedüs L. Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules. Eur J Endocrinol. 2007; 157: 95-100.
54. Døssing H, Bennedbaek F.N., Hegedüs L. Interstitial laser photocoagulation (ILP) of benign cystic thyroid nodules-a prospective randomized trial. J Clin Endocrinol Metab. 2013; 98: E1213-E1217.
55. Di Rienzo G., Surrente C, Lopez C., Quercia R. Tracheal laceration after laser ablation of nodular goitre. Interact Cardiovasc Thorac Surg. 2010; 14: 115-116.
56. Cakir B, Gul K, Ersoy R., Topaloglu O, Korukluoglu B. Subcapsular hematoma complication during percutaneous laser ablation to a hypoactive benign solitary thyroid nodule. Thyroid. 2008; 18: 917-918.
57. Cakir B, Ugras NS, Gul K, Ersoy R, Korukluoglu B. Initial report of the results of percutaneous laser ablation of benign cold thyroid nodules: evaluation of histopathological changes after 2 years. Endocr Pathol. 2009; 20: 170-176.
58. Piana S, Frasoldati A, Ferrari M., et al Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18, 000 FNAs reported at the same institution during 1998-2007. Cytopathology. 2011; 22: 164-173.
59. Feng B, Liang P, Cheng Z., et al Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: experimental and clinical studies. Eur J Endocrinol. 2012; 166: 1031-1037.
60. Esnault O, Franc B, Monteil J.P., Chapelon JY High-intensity focused ultrasound for localized thyroid-tissue ablation: preliminary experimental animal study. Thyroid. 2004; 14: 1072-1076.
61. Esnault O, Rouxel A, Le Nestour E, Gheron G, Leenhardt L. Minimally invasive ablation of a toxic thyroid nodule by high-intensity focusedultrasound. AJNR Am J Neuroradiol. 2010; 31: 1967-1968.
62. Esnault O, Franc B, Ménégaux F, et al. High-intensity focused ultrasound ablation of thyroid nodules: first human feasibility study. Thyroid. 2011; 21: 965-973.
63. Monzani F, Caraccio N, Basolo F., Iacconi P, Livolsi V, Miccoli P. Surgical and pathological changes after percutaneous ethanol injection therapy of thyroid nodules. Thyroid. 2000; 10: 1087-1092.
64. Monchik JM, Donatini G, Iannuccilli J., Dupuy DE Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg. 2006; 244: 296-304.
65. Dupuy DE, Monchik JM, Decrea C, Pisharodi L. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery. 2001; 130: 971-977.
66. Baek JH, Kim YS, Sung J.Y., Choi H., Lee JH Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. AJR Am J Roentgenol. 2011; 197: W331-W336.
67. Park KW, Shin JH, Han B.K., Ko EY, Chung JH Inoperable symptomatic recurrent thyroid cancers: preliminary result of radiofre-quency ablation. Ann Surg Oncol. 2011; 18: 2564-2568.
68. Papini E, Bizzarri G, Bianchini A., et al Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer. J Clin Endocrinol Metab. 2013; 98: E92-E97.
69. Pacella CM, Papini E. Image-guided percutaneous ablation therapies for local recurrences of thyroid tumors. J Endocrinol Invest. 2013; 36: 61-70.